ホーム > 市場調査レポート > 医薬品 > OTC > 欧州6大市場におけるセルフメディケーション用鎮痛剤
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

欧州6大市場におけるセルフメディケーション用鎮痛剤

Pain Relief in Self-medication in Europe 6 Country Market Study - The 2005 edition

発行 James Dudley International, Ltd.
出版日 2005年04月 商品コード 29458
ページ情報 英文  
価格
こちらの商品の販売は終了いたしました。

当商品の販売は、2011年07月19日を持ちまして終了しました。

原文目次

Abstract

This is the third edition of this important and extensive market report covering Europes six largest markets -- France, Germany, Italy, Poland, Spain and the UK. The third edition has been expanded to explore self-medication opportunities for joint and muscle pain relief, teething and mouth ulcer pain, dysmenorrhoea and migraine as well as general pain analgesics and topical medication.

This is a statistically based consultancy study researched and written by the James Dudley Management team. Most current data is to 2004.

The European market for non-prescription pain relief is entering a period of considerable change particularly in areas of regulation, reimbursement, innovation and competition. In an increasingly competitive and maturing market successful companies are adapting their brand marketing strategies to meet new challenges and seize new opportunities.

This in-depth market study explores the issues and attractiveness of opportunities in this dynamic market sector.

  • 6 country profiles -- regulatory issues, distribution channels, innovation, companies and market data and trends from 1999 to 2010
  • Leading brands, companies and sales data for general analgesics, topical pain relief, joint and muscle pain, teething and mouth ulcer pain, dysmenorrhoea and migraine relief
  • Analysis of the European market for pain relief medication, consumption trends, innovation and evolving brand marketing models.
Back to Top